The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccrol Gp Regulatory News (ACRL)

Share Price Information for Accrol Gp (ACRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.60
Bid: 38.60
Ask: 38.70
Change: 0.40 (1.05%)
Spread: 0.10 (0.259%)
Open: 38.30
High: 40.70
Low: 37.70
Prev. Close: 38.20
ACRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Revised Banking Arrangements & Operational Update

1 May 2018 07:00

RNS Number : 6644M
Accrol Group Holdings PLC
01 May 2018
 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

1 May 2018

Accrol Group Holdings plc

("Accrol", the "Company" or the "Group")

AIM: ACRL

 

REVISED BANKING ARRANGEMENTS, OPERATIONAL UPDATE AND CURRENT TRADING

 

Revised Banking Arrangements

 

Further to the information provided in the Trading Update announced on 19 March 2018 and following constructive discussions with its lender, Accrol announces that a number of matters regarding the Group's borrowing facilities have been agreed as outlined below:

 

· EBITDA covenants tests in respect of the periods ended 30 April 2018 and ending 31 July 2018 have been waived;

· the scheduled reduction in the limit of the Revolving Credit Facility which was due to occur on 30 April 2018 has been deferred until 31 October 2018; and

· indicative terms have been established for the lease funding of the new conversion line being installed at the Leyland plant in the next three months, which will allow the business to service major new business wins.

 

These revised banking arrangements, which are subject to the Company complying with certain undertakings to the lender during May 2018 (with which the Board expects to be able to comply) will help to support the growth of the business and enable the new management team to pursue the business recovery plan.

 

Operational Update

The Group is pleased to announce that it has recently entered heads of terms on the exit from the onerous central distribution hub in Skelmersdale. This planned exit is expected to have a positive impact on annualised profits, as previously reported, of at least £5 million.

Current Trading

 

The Company continues to trade in line with current market expectations.

 

 

For further information, please contact:

 

 

 

Accrol Group Holdings plc

 

Gareth Jenkins, Chief Executive Officer

Tel: +44 (0) 1254 278 844

Martin Leitch, Interim Chief Finance Officer

Tel: +44 (0) 1254 278 844

 

 

Zeus Capital Limited (Nominated Adviser & Broker) 

 

Dan Bate / Andrew Jones

Tel: +44 (0) 161 831 1512

Dominic King / John Goold

 Tel: +44 (0) 203 829 5000

 

 

Belvedere Communications Limited

 

Cat Valentine (cvalentine@belvederepr.com)

Tel: +44 (0) 7715 769 078

 

Notes to Editors

 

Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues as well as other tissue products to the UK's largest retailers. 

Accrol operates from three sites:

· A manufacturing, storage and distribution facility in Blackburn;

· A facial tissue plant, also in Blackburn; and

· A manufacturing, storage and distribution facility in Leyland.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKMGFDZGNGRZZ
Date   Source Headline
5th Oct 20177:00 amRNSTrading Update and Temporary Suspension of Trading
22nd Sep 20172:47 pmRNSResult of AGM
19th Sep 20173:16 pmRNSHolding(s) in Company
7th Sep 20177:00 amRNSAppointment of Chief Executive and Trading Update
10th Aug 20177:00 amRNSPosting of Accounts & Notice of AGM (Replacement)
9th Aug 20177:00 amRNSPosting of Accounts & Notice of AGM - Date change
10th Jul 20177:01 amRNSAppointment of Joint Corporate Broker
10th Jul 20177:00 amRNSPreliminary results for year ended 30 April 2017
26th Jun 20179:06 amRNSInvestment in new manufacturing line for Leyland
23rd Jun 201710:15 amEQSLily & Piper Limited: Small Cap Awards 2017
16th May 20177:00 amRNSTrading Update, New Facilities & Notice of Results
6th Apr 201712:00 pmRNSOfficial opening of new manufacturing facility
9th Jan 20173:43 pmRNSHolding(s) in Company
4th Jan 20177:00 amRNSInterim results for six months ended 31 Oct 2016
14th Dec 20167:00 amRNSNotice of interim results date change
7th Nov 20167:00 amRNSPre-close trading statement
30th Sep 201612:07 pmRNSResult of AGM
29th Sep 20164:33 pmRNSDirector's Dealing
22nd Sep 20161:06 pmRNSHolding(s) in Company
2nd Sep 20167:00 amRNSNew manufacturing facility
4th Aug 20164:56 pmRNSHolding(s) in Company
22nd Jul 20167:00 amRNSFull year results for the year ended 30 April 2016
11th Jul 20167:00 amRNSDeferred Share Buyback
8th Jul 20167:00 amRNSContract Win and Trading Update
14th Jun 20165:12 pmRNSHolding(s) in Company
13th Jun 20166:18 pmRNSHolding(s) in Company
13th Jun 20166:01 pmRNSHolding(s) in Company
13th Jun 20165:57 pmRNSHolding(s) in Company
13th Jun 20164:03 pmRNSHolding(s) in Company
13th Jun 20161:45 pmRNSHolding(s) in Company
13th Jun 201612:28 pmRNSHolding(s) in Company
10th Jun 20167:00 amRNSFirst Day of Dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.